BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fidler IJ, Kripke ML. The challenge of targeting metastasis. Cancer Metastasis Rev. 2015;34:635-641. [PMID: 26328524 DOI: 10.1007/s10555-015-9586-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang N, Zhang H, Cui X, Ma C, Wang L, Liu W. Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile. Int J Mol Sci 2021;22:2219. [PMID: 33672337 DOI: 10.3390/ijms22042219] [Reference Citation Analysis]
2 Giarra S, Ierano C, Biondi M, Napolitano M, Campani V, Pacelli R, Scala S, De Rosa G, Mayol L. Engineering of thermoresponsive gels as a fake metastatic niche. Carbohydr Polym 2018;191:112-8. [PMID: 29661298 DOI: 10.1016/j.carbpol.2018.03.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Jiang X, Wu M, Xu Z, Wang H, Wang H, Yu X, Li Z, Teng L. HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer. Cancer Manag Res 2018;10:6857-67. [PMID: 30588091 DOI: 10.2147/CMAR.S188364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
4 Jian B, Zhang H, Han C, Liu J. Anti-Cancer Activities of Diterpenoids Derived from Euphorbia fischeriana Steud. Molecules 2018;23:E387. [PMID: 29439483 DOI: 10.3390/molecules23020387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
5 Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock TNJ, Slingluff CL Jr, Ravichandran KS, Parsons JT, Bauer TW. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res. 2018;24:1415-1425. [PMID: 29288236 DOI: 10.1158/1078-0432.ccr-17-2283] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 9.8] [Reference Citation Analysis]
6 Zhao LJ, Fan QQ, Li YY, Ren HM, Zhang T, Liu S, Maa M, Zheng YC, Liu HM. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9. Pharmacol Res 2020;159:104991. [PMID: 32504836 DOI: 10.1016/j.phrs.2020.104991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R, Marshall JF, Panico MB, Shaw JA, Steeg PS, Sullivan M, Tong W, Westwell AD, Ritchie JWA; Cancer Research UK and Cancer Therapeutics CRC Australia Metastasis Working Group. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16:185-204. [PMID: 30514977 DOI: 10.1038/s41571-018-0134-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 43.5] [Reference Citation Analysis]
8 Li H, Wang Z, Chen Z, Ci T, Chen G, Wen D, Li R, Wang J, Meng H, Bryan Bell R, Gu Z, Dotti G, Gu Z. Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis. Nat Commun 2021;12:2773. [PMID: 33986264 DOI: 10.1038/s41467-021-22674-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kong F, Li L, Wang C, Zhang Q, He S. MiR-381-3p suppresses biological characteristics of cancer in head-neck squamous cell carcinoma cells by targeting nuclear autoantigenic sperm protein (NASP). Bioscience, Biotechnology, and Biochemistry 2020;84:703-13. [DOI: 10.1080/09168451.2019.1697195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 He B, Ganss R. Modulation of the Vascular-Immune Environment in Metastatic Cancer. Cancers (Basel) 2021;13:810. [PMID: 33671981 DOI: 10.3390/cancers13040810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wu J, Yang T, Wang X, Li W, Pang M, Sun H, Liang H, Yang F. Development of a multi-target anticancer Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complex. Dalton Trans 2021;50:10909-21. [PMID: 34313274 DOI: 10.1039/d1dt01272j] [Reference Citation Analysis]
12 Shin PJ, Zhu Z, Camarda R, Bok RA, Zhou AY, Kurhanewicz J, Goga A, Vigneron DB. Cancer recurrence monitoring using hyperpolarized [1-13C]pyruvate metabolic imaging in murine breast cancer model. Magn Reson Imaging 2017;43:105-9. [PMID: 28716678 DOI: 10.1016/j.mri.2017.07.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Izraely S, Ben-Menachem S, Sagi-Assif O, Meshel T, Marzese DM, Ohe S, Zubrilov I, Pasmanik-Chor M, Hoon DSB, Witz IP. ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis. Oncotarget 2017;8:75778-96. [PMID: 29100268 DOI: 10.18632/oncotarget.19018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ranjan A, Iyer SV, Ward C, Link T, Diaz FJ, Dhar A, Tawfik OW, Weinman SA, Azuma Y, Izumi T, Iwakuma T. MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma. Oncotarget 2018;9:21429-43. [PMID: 29765550 DOI: 10.18632/oncotarget.25117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mendes Miranda SE, Alcântara Lemos J, Fernandes RS, Silva JO, Ottoni FM, Townsend DM, Rubello D, Alves RJ, Cassali GD, Ferreira LAM, de Barros ALB. Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model. Biomed Pharmacother 2021;133:110936. [PMID: 33254016 DOI: 10.1016/j.biopha.2020.110936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Quinn JJ, Jones MG, Okimoto RA, Nanjo S, Chan MM, Yosef N, Bivona TG, Weissman JS. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science 2021;371:eabc1944. [PMID: 33479121 DOI: 10.1126/science.abc1944] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 31.0] [Reference Citation Analysis]
17 Silvestri M, Reduzzi C, Feliciello G, Vismara M, Schamberger T, Köstler C, Motta R, Calza S, Ferraris C, Vingiani A, Pruneri G, Daidone MG, Klein CA, Polzer B, Cappelletti V. Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers (Basel) 2021;13:1409. [PMID: 33808748 DOI: 10.3390/cancers13061409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wu JI, Lin YP, Tseng CW, Chen HJ, Wang LH. Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling. Sci Rep 2019;9:845. [PMID: 30696915 DOI: 10.1038/s41598-018-37443-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
19 Oliveira RC, Abrantes AM, Tralhão JG, Botelho MF. The role of mouse models in colorectal cancer research-The need and the importance of the orthotopic models. Animal Model Exp Med 2020;3:1-8. [PMID: 32318654 DOI: 10.1002/ame2.12102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
20 Muramatsu M, Akakura S, Gao L, Peresie J, Balderman B, Gelman IH. SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk. Oncotarget 2018;9:33515-27. [PMID: 30323895 DOI: 10.18632/oncotarget.26067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li L, Yan S, Zhang H, Zhang M, Huang G, Chen M. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. BMC Cancer 2019;19:894. [PMID: 31492158 DOI: 10.1186/s12885-019-6119-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Serakinci N, Cagsin H. Turning stem cells homing potential into cancer specific drug delivery machines. Ann Transl Med 2019;7:S148. [PMID: 31576355 DOI: 10.21037/atm.2019.06.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Jia Y, Wang Y, Zhang C, Chen MY. Upregulated CBX8 Promotes Cancer Metastasis via the WNK2/MMP2 Pathway. Mol Ther Oncolytics 2020;19:188-96. [PMID: 33251331 DOI: 10.1016/j.omto.2020.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Deng W, Han W, Fan T, Wang X, Cheng Z, Wan B, Chen J. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN. Biomed Pharmacother 2018;107:1505-13. [PMID: 30257368 DOI: 10.1016/j.biopha.2018.08.127] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
25 Twum DY, Colligan SH, Hoffend NC, Katsuta E, Cortes Gomez E, Hensen ML, Seshadri M, Nemeth MJ, Abrams SI. IFN regulatory factor-8 expression in macrophages governs an antimetastatic program. JCI Insight 2019;4:124267. [PMID: 30728331 DOI: 10.1172/jci.insight.124267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
26 Niu W, Xu L, Li J, Zhai Y, Sun Z, Shi W, Jiang Y, Ma C, Lin H, Guo Y, Liu Z. Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs. Oncol Lett 2020;20:2928-36. [PMID: 32782609 DOI: 10.3892/ol.2020.11839] [Reference Citation Analysis]
27 Saxena S, Prajapati DR, Goel P, Tomar B, Hayashi Y, Atri P, Rachagani S, Grandgenett PM, Hollingsworth MA, Batra SK, Singh RK. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. Cancers (Basel) 2021;13:818. [PMID: 33669221 DOI: 10.3390/cancers13040818] [Reference Citation Analysis]
28 Puls TJ, Tan X, Husain M, Whittington CF, Fishel ML, Voytik-Harbin SL. Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening. Sci Rep 2018;8:13039. [PMID: 30158688 DOI: 10.1038/s41598-018-31138-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
29 Ciavatta ML, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T, Dasari R, Kornienko A, Kiss R. Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Med Res Rev 2017;37:702-801. [PMID: 27925266 DOI: 10.1002/med.21423] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
30 Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76. [PMID: 31300030 DOI: 10.1186/s13045-019-0760-3] [Cited by in Crossref: 203] [Cited by in F6Publishing: 187] [Article Influence: 101.5] [Reference Citation Analysis]
31 Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, Abotaleb M, Biringer K, Kudela E, Danko J, Shakibaei M, Kwon TK, Büsselberg D, Kubatka P. Flavonoids in Cancer Metastasis. Cancers (Basel) 2020;12:E1498. [PMID: 32521759 DOI: 10.3390/cancers12061498] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 33.0] [Reference Citation Analysis]
32 Jonkers J, Pai P, Sukumar S. Multiple roles of HOX proteins in Metastasis: Let me count the ways. Cancer Metastasis Rev 2020;39:661-79. [PMID: 32572656 DOI: 10.1007/s10555-020-09908-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
33 El Hassouni B, Granchi C, Vallés-martí A, Supadmanaba IGP, Bononi G, Tuccinardi T, Funel N, Jimenez CR, Peters GJ, Giovannetti E, Minutolo F. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies. Seminars in Cancer Biology 2020;60:238-48. [DOI: 10.1016/j.semcancer.2019.08.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
34 White SB, Procissi D, Chen J, Gogineni VR, Tyler P, Yang Y, Omary RA, Larson AC. Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases. PLoS One 2016;11:e0155334. [PMID: 27171151 DOI: 10.1371/journal.pone.0155334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
35 Tian X, Yu H, Li D, Jin G, Dai S, Gong P, Kong C, Wang X. The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer. Mol Ther 2021;29:1239-57. [PMID: 33221433 DOI: 10.1016/j.ymthe.2020.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Osrodek M, Wozniak M. Targeting Genome Stability in Melanoma-A New Approach to an Old Field. Int J Mol Sci 2021;22:3485. [PMID: 33800547 DOI: 10.3390/ijms22073485] [Reference Citation Analysis]
37 Lee JW, Beatty GL. Inflammatory networks cultivate cancer cell metastasis to the liver. Cell Cycle 2020;19:642-51. [PMID: 32053029 DOI: 10.1080/15384101.2020.1728013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Song M, Wang J, Lei J, Peng G, Zhang W, Zhang Y, Yin M, Li J, Liu Y, Wei X, Li X, Li G. Preparation and Evaluation of Liposomes Co-Loaded with Doxorubicin, Phospholipase D Inhibitor 5-Fluoro-2-Indolyl Deschlorohalopemide (FIPI) and D-Alpha Tocopheryl Acid Succinate (α-TOS) for Anti-Metastasis. Nanoscale Res Lett 2019;14:138. [PMID: 31001703 DOI: 10.1186/s11671-019-2964-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Croucher PI, McDonald MM, Martin TJ. Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer. 2016;16:373-386. [PMID: 27220481 DOI: 10.1038/nrc.2016.44] [Cited by in Crossref: 225] [Cited by in F6Publishing: 186] [Article Influence: 56.3] [Reference Citation Analysis]
40 Vázquez R, Riveiro ME, Berenguer-Daizé C, O'Kane A, Gormley J, Touzelet O, Rezai K, Bekradda M, Ouafik L. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy. Front Oncol 2020;10:589218. [PMID: 33489885 DOI: 10.3389/fonc.2020.589218] [Reference Citation Analysis]
41 Weidle UH, Birzele F, Nopora A. MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer. Cancer Genomics Proteomics 2019;16:99-119. [PMID: 30850362 DOI: 10.21873/cgp.20116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
42 Rahbari M, Rahbari N, Reissfelder C, Weitz J, Kahlert C. Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer. Langenbecks Arch Surg. 2016;401:1097-1110. [PMID: 27342853 DOI: 10.1007/s00423-016-1468-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
43 He B, Johansson-Percival A, Backhouse J, Li J, Lee GYF, Hamzah J, Ganss R. Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy. Cell Rep 2020;30:714-724.e5. [PMID: 31968248 DOI: 10.1016/j.celrep.2019.12.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
44 Shen C, Yan T, Tong T, Shi D, Ren L, Zhang Y, Zhang X, Cao Y, Yan Y, Ma Y, Zhu X, Tian X, Fang JY, Chen H, Ji L, Hong J, Xuan B. ALKBH4 Functions as a Suppressor of Colorectal Cancer Metastasis via Competitively Binding to WDR5. Front Cell Dev Biol 2020;8:293. [PMID: 32478065 DOI: 10.3389/fcell.2020.00293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
45 Woythe L, Tito NB, Albertazzi L. A quantitative view on multivalent nanomedicine targeting. Adv Drug Deliv Rev 2021;169:1-21. [PMID: 33264593 DOI: 10.1016/j.addr.2020.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
46 Lobos-González L, Bustos R, Campos A, Silva V, Silva V, Jeldes E, Salomon C, Varas-Godoy M, Cáceres-Verschae A, Duran E, Vera T, Ezquer F, Ezquer M, Burzio VA, Villegas J. Exosomes released upon mitochondrial ASncmtRNA knockdown reduce tumorigenic properties of malignant breast cancer cells. Sci Rep 2020;10:343. [PMID: 31941923 DOI: 10.1038/s41598-019-57018-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Kim KC, Yun J, Son DJ, Kim JY, Jung JK, Choi JS, Kim YR, Song JK, Kim SY, Kang SK, Shin DH, Roh YS, Han SB, Hong JT. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1. Theranostics 2018;8:4409-28. [PMID: 30214629 DOI: 10.7150/thno.26467] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
48 Wrenn ED, Yamamoto A, Moore BM, Huang Y, McBirney M, Thomas AJ, Greenwood E, Rabena YF, Rahbar H, Partridge SC, Cheung KJ. Regulation of Collective Metastasis by Nanolumenal Signaling. Cell 2020;183:395-410.e19. [PMID: 33007268 DOI: 10.1016/j.cell.2020.08.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
49 Haro MA, Dyevoich AM, Phipps JP, Haas KM. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Res 2019;79:159-70. [PMID: 30224373 DOI: 10.1158/0008-5472.CAN-18-0981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
50 Zhang W, Wang F, Hu C, Zhou Y, Gao H, Hu J. The progress and perspective of nanoparticle-enabled tumor metastasis treatment. Acta Pharm Sin B 2020;10:2037-53. [PMID: 33304778 DOI: 10.1016/j.apsb.2020.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 27.0] [Reference Citation Analysis]
51 Chen WW, Zhang HR, Huang ZG, Zhou ZY, Lou QW, Jiang XY, Zhu ZH. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity. Protein Expr Purif 2021;185:105893. [PMID: 33933613 DOI: 10.1016/j.pep.2021.105893] [Reference Citation Analysis]
52 Kiweler N, Wünsch D, Wirth M, Mahendrarajah N, Schneider G, Stauber RH, Brenner W, Butter F, Krämer OH. Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. J Cancer Res Clin Oncol 2020;146:343-56. [PMID: 31932908 DOI: 10.1007/s00432-019-03118-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
53 Bie B, Sun J, Guo Y, Li J, Jiang W, Yang J, Huang C, Li Z. Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomedicine & Pharmacotherapy 2017;93:1285-91. [DOI: 10.1016/j.biopha.2017.07.068] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 14.5] [Reference Citation Analysis]
54 Qian J, Ji F, Ye X, Cheng H, Ma R, Chang X, Shou C, Cui H. IGHG1 promotes motility likely through epithelial-mesenchymal transition in ovarian cancer. Chin J Cancer Res 2018;30:282-90. [PMID: 29861613 DOI: 10.21147/j.issn.1000-9604.2018.02.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Singh B, Sarli VN, Kinne HE, Shamsnia A, Lucci A. Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential. Oncotarget 2019;10:3681-93. [PMID: 31217902 DOI: 10.18632/oncotarget.26978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Xu HT, Miao J, Liu JW, Zhang LG, Zhang QG. Prognostic value of circulating tumor cells in esophageal cancer. World J Gastroenterol 2017;23:1310-8. [PMID: 28275311 DOI: 10.3748/wjg.v23.i7.1310] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Izraely S, Witz IP. Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment. Int J Cancer 2021;148:1308-22. [PMID: 32761606 DOI: 10.1002/ijc.33247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Wu J, Wang Y, Xu X, Cao H, Sahengbieke S, Sheng H, Huang Q, Lai M. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer. Carcinogenesis 2016;37:511-21. [PMID: 26964871 DOI: 10.1093/carcin/bgw029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
59 Schiemann WP. Introduction to this special issue "Breast Cancer Metastasis". J Cancer Metastasis Treat 2020;6. [PMID: 34277953 DOI: 10.20517/2394-4722.2020.01] [Reference Citation Analysis]
60 Greco MR, Moro L, Forciniti S, Alfarouk K, Cannone S, Cardone RA, Reshkin SJ. Integrin-Linked Kinase Links Integrin Activation to Invadopodia Function and Invasion via the p(T567)-Ezrin/NHERF1/NHE1 Pathway. Int J Mol Sci 2021;22:2162. [PMID: 33671549 DOI: 10.3390/ijms22042162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Martín-Cortázar C, Chiodo Y, Jiménez RP, Bernabé M, Cayuela ML, Iglesias T, Campanero MR. CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion. Haematologica 2020;105:730-40. [PMID: 31221787 DOI: 10.3324/haematol.2018.215459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
62 Jiang Y, Liang Y, Li L, Zhou L, Cheng W, Yang X, Yang X, Qi H, Yu J, Jeong LS, Hoffman RM, Zheng P, Jia L. Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung-cancer metastasis. Cell Biol Toxicol 2019;35:233-45. [PMID: 31140025 DOI: 10.1007/s10565-019-09472-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
63 Zhou R, Tang X, Li L, Zhang F, Sun J, Ju C, Zhou Y, Liu R, Liang Y, Lv B, Zhang Z, Hu H, Lv XB. Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:531-9. [PMID: 32021462 DOI: 10.2147/CMAR.S232632] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 He X, Huang N, Qiu Y, Zhang J, Liu Y, Yin XL, Lu S. Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors. Molecules 2021;26:962. [PMID: 33670371 DOI: 10.3390/molecules26040962] [Reference Citation Analysis]
65 Kähkönen TE, Halleen JM, Bernoulli J. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells 2021;10:1529. [PMID: 34204474 DOI: 10.3390/cells10061529] [Reference Citation Analysis]